Lamotrigine vs Pembrolizumab

## Lamotrigine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Lamotrigine** and **Pembrolizumab**.

## Mechanism of Action

**Lamotrigine**: Sodium channel blocker inhibiting glutamate release.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Lamotrigine — 25 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Lamotrigine — C9H7Cl2N5; Pembrolizumab — N/A.

**Molecular Weight**: Lamotrigine — 256.0910 g/mol; Pembrolizumab — N/A.

**Type**: Lamotrigine — Small molecule; Pembrolizumab — Antibody.